Clinical impact of pharmacokinetically-guided dose adaptation of 5-fluorouracil: results from a multicentric randomized trial in patients with locally advanced head and neck carcinomas.R. Féty, G. Milano, L. Campion et al.|PubMed|1998Cited by 114
In vitro comparative evaluation of trastuzumab (Herceptin®) combined with paclitaxel (Taxol®) or docetaxel (Taxotere®) in HER2-expressing human breast cancer cell linesJean‐Louis Merlin, Nicolas Bachmann|Annals of Oncology|2002Cited by 82
Clinical randomized study of 5FU monitoring versus standard dose in patients with head and neck cancer: preliminary results.R. Féty, G. Milano, F. Rolland et al.|PubMed|1995Cited by 21